These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6391986)
1. Characterization of immunoreactive insulin in human saliva: evidence against production in situ. Vallejo G; Mead PM; Gaynor DH; Devlin JT; Robbins DC Diabetologia; 1984 Oct; 27(4):437-40. PubMed ID: 6391986 [TBL] [Abstract][Full Text] [Related]
2. Salivary insulin concentrations in type 2 (non-insulin-dependent) diabetic patients and obese non-diabetic subjects: relationship to changes in plasma insulin levels after an oral glucose load. Marchetti P; Benzi L; Masoni A; Cecchetti P; Giannarelli R; Di Cianni G; Ciccarone AM; Navalesi R Diabetologia; 1986 Oct; 29(10):695-8. PubMed ID: 3542670 [TBL] [Abstract][Full Text] [Related]
3. Glucose-dependent insulinotropic polypeptide and insulin-like immunoreactivity in saliva following sham-fed and swallowed meals. Messenger B; Clifford MN; Morgan LM J Endocrinol; 2003 Jun; 177(3):407-12. PubMed ID: 12773121 [TBL] [Abstract][Full Text] [Related]
4. Peptide hormones in saliva. I. Insulin in saliva during the oral glucose tolerance test in female patients. Simionescu L; Aman E; Muşeţeanu P; Dinulescu E; Giurcăneanu M Endocrinologie; 1985; 23(3):179-87. PubMed ID: 3901231 [TBL] [Abstract][Full Text] [Related]
5. Salivary immunoreactive insulin concentrations are related to plasma free-insulin levels in insulin-treated diabetic patients. Marchetti P; Giannarelli R; Masoni A; Cecchetti P; Di Carlo A; Navalesi R Diabete Metab; 1990; 16(1):16-20. PubMed ID: 2185053 [TBL] [Abstract][Full Text] [Related]
6. Lack of insulinotropic effect of endogenous and exogenous cholecystokinin in man. Reimers J; Nauck M; Creutzfeldt W; Strietzel J; Ebert R; Cantor P; Hoffmann G Diabetologia; 1988 May; 31(5):271-80. PubMed ID: 3294066 [TBL] [Abstract][Full Text] [Related]
7. Serum-to-saliva transfer of the immunoreactive insulin (IRI) in children with obesity associated with insulin-resistance. Popa M; Simionescu L; Dumitriu E; Dimitriu V; Giurcãneanu M; Bartoc R; Dinulescu E Endocrinologie; 1987; 25(3):149-55. PubMed ID: 3317776 [TBL] [Abstract][Full Text] [Related]
8. [Determination of insulin in saliva and its correlation with plasma insulin. Assessment of the possible participation++ of the salivary glands in the production of the hormone]. Sánchez García P; de Portugal Alvarez J; Alonso Gutiérrez D; Cruz Hernández JJ An Med Interna; 1989 Jan; 6(1):5-9. PubMed ID: 2491037 [TBL] [Abstract][Full Text] [Related]
9. Salivary insulin in normal and type I diabetic subjects. Pasic J; Pickup JC Diabetes Care; 1988 Jun; 11(6):489-94. PubMed ID: 3042316 [TBL] [Abstract][Full Text] [Related]
10. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus. Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885 [TBL] [Abstract][Full Text] [Related]
11. Salivary immunoreactive insulin: a new entry in clinical chemistry? Marchetti P; Grossi C; Giannarelli R; Masoni A; Cristofani R; Giannecchini M; Navales R Clin Chem; 1988 Jul; 34(7):1478-80. PubMed ID: 3292086 [TBL] [Abstract][Full Text] [Related]
13. Hepatic extraction of insulin after stimulation of secretion with oral glucose or parenteral nutrients. Dupré J; Behme MT; Hramiak IM; Longo CJ Metabolism; 1993 Aug; 42(8):921-7. PubMed ID: 8345813 [TBL] [Abstract][Full Text] [Related]
14. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Bruttomesso D; Pianta A; Mari A; Valerio A; Marescotti MC; Avogaro A; Tiengo A; Del Prato S Diabetes; 1999 Jan; 48(1):99-105. PubMed ID: 9892228 [TBL] [Abstract][Full Text] [Related]
15. The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus. Jones IR; Owens DR; Luzio S; Williams S; Hayes TM Diabetologia; 1989 Sep; 32(9):668-77. PubMed ID: 2676668 [TBL] [Abstract][Full Text] [Related]
16. Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans. Wilding JP; Khandan-Nia N; Bennet WM; Gilbey SG; Beacham J; Ghatei MA; Bloom SR Diabetologia; 1994 Feb; 37(2):166-9. PubMed ID: 8163050 [TBL] [Abstract][Full Text] [Related]
17. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8. Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324 [TBL] [Abstract][Full Text] [Related]
18. Glucose, fructosamine, and insulin measurements in saliva of dogs: variations after an experimental glucose administration. Muñoz-Prieto A; Escribano D; Cerón JJ; Martínez-Subiela S; Tvarijonaviciute A Domest Anim Endocrinol; 2019 Jan; 66():64-71. PubMed ID: 30472034 [TBL] [Abstract][Full Text] [Related]
19. Effects of intraduodenal administration of HCl and glucose on circulating immunoreactive secretin and insulin concentrations. Boden G; Essa N; Owen OE; Reichle FA J Clin Invest; 1974 Apr; 53(4):1185-93. PubMed ID: 4815082 [TBL] [Abstract][Full Text] [Related]
20. Oral glucose ingestion stimulates cholecystokinin release in normal subjects and patients with non-insulin-dependent diabetes mellitus. Hasegawa H; Shirohara H; Okabayashi Y; Nakamura T; Fujii M; Koide M; Otsuki M Metabolism; 1996 Feb; 45(2):196-202. PubMed ID: 8596489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]